ClinicalTrials.Veeva

Menu

Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study

Johns Hopkins University logo

Johns Hopkins University

Status

Completed

Conditions

Covid19
Pneumonia, Viral

Treatments

Other: Prone Positioning

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04517123
IRB00249663

Details and patient eligibility

About

The overall objective of this study is to determine whether a positional maneuver (e.g., prone positioning) decreases the need for escalation of respiratory-related care in patients with coronavirus (COVID-19) pneumonia.

Full description

As the initial outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes, coronavirus disease 2019 (COVID-19) has spread beyond Wuhan, China it has become a pandemic affecting over 178 countries. Of patients admitted to the ICU, upwards of 85% developed the acute respiratory distress syndrome (ARDS) and most if not all required mechanical ventilation. The beneficial effects of prone positioning for ARDS have been well described. Coupling the reported benefits of prone positioning in COVID-19 associated ARDS patients with the known beneficial effects of early prone-positioning in the treatment of ARDS, it is not surprising that many hospital systems are advocating prone positioning for treatment of ARDS in patients with COVID-19. However, as the pandemic continues to progress in the United States and the number of new cases grows as new clusters emerge, the possibility of 'rationing' ventilators becomes more real. Therefore, therapies that prevent the need for mechanical ventilation are desperately needed. Given the distinct benefit that patients with COVID-19 have with prone positioning, the overarching hypothesis of this trial is that patients with high risk for respiratory failure may also benefit from prone positioning.

Enrollment

35 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • COVID-19 positive by nasopharyngeal swab or serostatus
  • Use of supplemental oxygen OR respiratory rate ≥ 20

Exclusion criteria

  • BMI ≥ 45 kg/m2
  • Pregnancy
  • Chest tube placement
  • Hemodynamic instability with mean arterial pressure < 60 mmHg
  • Thoracic or abdominal wounds
  • Chest wall deformities
  • Vertebral column deformities that would preclude prone positioning
  • Facial trauma or surgery in the last 30 days
  • Established diagnosis of interstitial lung disease
  • Prior single or double lung transplant
  • Surgery for spine, femur, or pelvis in the last 3 months
  • Thoracic or cardiac surgery in the last 30 days
  • Pacemaker placement last 7 days

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

35 participants in 2 patient groups

Control - Usual Care
No Intervention group
Description:
Usual Care
Intervention - Prone Positioning
Experimental group
Description:
Prone Positioning
Treatment:
Other: Prone Positioning

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems